Key Event Details
- Event: Conference Call to discuss financial results and performance for Q1 FY27 (quarter ended 30th June 2026).
- Date & Time: Monday, 17th August 2026, from 17:00 hrs to 18:00 hrs IST.
- Disclosure Date: 12th August 2026.
Management Participants
- Mr. Harshil Dalal, Global CFO.
- Mr. Stephan Fritschi, Chief Executive Officer, Carbogen Amcis Entities.
Logistical Information
Primary Dial-in Numbers: 086 3416 8589 / 086 4536 7374
International Toll-Free Numbers:
- USA: 18773870849
- UK: 08000163439
- Singapore: 8001011941
- Hong Kong: 800903171
International Participation PIN: 8630176#
Pre-registration Facility: Available via https://ir.dsnl.in/login for direct dial-in without operator wait times (DiamondPassTM).
Company Background
Dishman Carbogen Amcis Limited is a fully integrated Contract Development and Manufacturing Organisation (CDMO) established in 1983. The company provides end-to-end services from process R&D to commercial manufacturing of APIs for innovator pharmaceutical companies.
Global Presence: Development and manufacturing sites in Switzerland, UK, France, Netherlands, India, and China.
Product Offerings: APIs, High Potent APIs, Intermediates, Phase Transfer Catalysts, Vitamin D Analogues, Cholesterol, Lanolin-related products, Antiseptic and Disinfectant formulations.